SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-06-000463
Filing Date
2006-05-11
Accepted
2006-05-11 17:00:20
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND, II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-migenix_sc13g.htm SC 13G 103569
2 AGREEMENT REGARDING JOINT FILING exhibit_99.htm EX-99 12913
  Complete submission text file 0000898432-06-000463.txt   118834
Mailing Address BC RESEARCH COMPLEX 3650 WESBROOK MALL VANCOUVER A1 V6S2L2
Business Address 1750 609 GRANVILLE ST VANCOUVER B C CANADA A1 00000 (604) 221-9666
MIGENIX Inc. (Subject) CIK: 0000915458 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0430
Type: SC 13G | Act: 34 | File No.: 005-78624 | Film No.: 06830896
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice